iShares Global Healthcare ETF (NYSEARCA:IXJ) Reaches New 52-Week High – Should You Buy?

iShares Global Healthcare ETF (NYSEARCA:IXJ) reached a new 52-week high on Tuesday . The company traded as high as $102.20 and last traded at $102.11, with a volume of 24947 shares traded. The stock had previously closed at $100.46.

iShares Global Healthcare ETF Stock Up 1.6%

The stock has a market cap of $4.14 billion, a price-to-earnings ratio of 21.58 and a beta of 0.57. The business has a 50-day moving average of $94.53 and a 200-day moving average of $96.31.

Institutional Trading of iShares Global Healthcare ETF

A number of institutional investors have recently added to or reduced their stakes in IXJ. Nvest Wealth Strategies Inc. acquired a new position in shares of iShares Global Healthcare ETF during the 4th quarter worth $30,000. Franklin Resources Inc. lifted its stake in shares of iShares Global Healthcare ETF by 80.0% in the 2nd quarter. Franklin Resources Inc. now owns 360 shares of the company’s stock valued at $31,000 after purchasing an additional 160 shares during the last quarter. Arax Advisory Partners acquired a new stake in shares of iShares Global Healthcare ETF in the 4th quarter valued at $31,000. LOM Asset Management Ltd boosted its holdings in iShares Global Healthcare ETF by 37.0% in the fourth quarter. LOM Asset Management Ltd now owns 407 shares of the company’s stock worth $40,000 after purchasing an additional 110 shares in the last quarter. Finally, Capital Investment Counsel Inc bought a new stake in iShares Global Healthcare ETF in the fourth quarter worth $42,000.

iShares Global Healthcare ETF Company Profile

iShares Global Healthcare ETF (the Fund), formerly iShares S&P Global Healthcare Sector Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the S&P Global 1200 Healthcare Sector Index (the Index). The Index measures the performance of companies that Standards & Poor’s Financial Services LLC (S&P) deems to be a part of the consumer staples sector of the economy. It is a subset of the S&P Global 1200 Index. Component companies include healthcare providers, biotechnology companies and manufacturers of medical supplies, advanced medical devices and pharmaceuticals.